Met Life Investment Management, LLC Esperion Therapeutics, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 71,050 shares of ESPR stock, worth $155,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
71,050
Previous 48,316 47.05%
Holding current value
$155,599
Previous $107,000 9.35%
% of portfolio
0.0%
Previous 0.0%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$1.61 - $2.73 $36,601 - $62,063
22,734 Added 47.05%
71,050 $117,000
Q2 2024

Aug 13, 2024
BUY
$1.84 - $3.24 $88,901 - $156,543
48,316 New
48,316 $107,000
Q1 2023

May 09, 2024
BUY
$1.46 - $7.3 $19,917 - $99,586
13,642 New
13,642 $21.7 Million
Q1 2023

May 15, 2023
SELL
$1.46 - $7.3 $30,724 - $153,621
-21,044 Reduced 60.67%
13,642 $21,000
Q4 2022

Jun 14, 2023
BUY
$5.09 - $8.5 $107,113 - $178,874
21,044 Added 154.26%
34,686 $216,000
Q3 2022

May 10, 2024
BUY
$5.45 - $8.13 $26,841 - $40,040
4,925 Added 16.55%
34,686 $232,000
Q3 2022

Jun 14, 2023
BUY
$5.45 - $8.13 $114,689 - $171,087
21,044 Added 154.26%
34,686 $232,000
Q3 2022

Mar 22, 2023
BUY
$5.45 - $8.13 $26,841 - $40,040
4,925 Added 16.55%
34,686 $232,000
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $26,841 - $40,040
4,925 Added 16.55%
34,686 $232,000
Q2 2022

May 10, 2024
SELL
$4.77 - $6.67 $25,514 - $35,677
-5,349 Reduced 15.23%
29,761 $189,000
Q2 2022

Jun 20, 2023
BUY
$4.77 - $6.67 $76,887 - $107,513
16,119 Added 118.16%
29,761 $189,000
Q2 2022

Mar 22, 2023
SELL
$4.77 - $6.67 $25,514 - $35,677
-5,349 Reduced 15.23%
29,761 $189,000
Q2 2022

Aug 11, 2022
SELL
$4.77 - $6.67 $25,514 - $35,677
-5,349 Reduced 15.23%
29,761 $189,000
Q1 2022

May 10, 2024
BUY
$3.34 - $5.56 $117,267 - $195,211
35,110 New
35,110 $162,000
Q1 2022

Jun 20, 2023
BUY
$3.34 - $5.56 $71,703 - $119,362
21,468 Added 157.37%
35,110 $162,000
Q1 2022

Mar 22, 2023
BUY
$3.34 - $5.56 $97,581 - $162,440
29,216 Added 495.69%
35,110 $162,000
Q1 2022

May 12, 2022
BUY
$3.34 - $5.56 $117,267 - $195,211
35,110 New
35,110 $163,000
Q4 2021

Feb 15, 2022
SELL
$4.81 - $11.92 $28,350 - $70,256
-5,894 Closed
0 $0
Q3 2021

May 17, 2024
SELL
$11.34 - $21.37 $77,021 - $145,145
-6,792 Reduced 53.54%
5,894 $71,000
Q3 2021

Jun 21, 2023
SELL
$11.34 - $21.37 $87,862 - $165,574
-7,748 Reduced 56.8%
5,894 $71,000
Q3 2021

Mar 22, 2023
SELL
$11.34 - $21.37 $77,021 - $145,145
-6,792 Reduced 53.54%
5,894 $71,000
Q3 2021

Nov 15, 2021
SELL
$11.34 - $21.37 $77,021 - $145,145
-6,792 Reduced 53.54%
5,894 $71,000
Q2 2021

Jun 21, 2023
SELL
$19.4 - $28.71 $18,546 - $27,446
-956 Reduced 7.01%
12,686 $268,000
Q1 2021

May 17, 2024
BUY
$25.12 - $36.89 $318,672 - $467,986
12,686 New
12,686 $355,000
Q1 2021

Jun 26, 2023
SELL
$25.12 - $36.89 $24,014 - $35,266
-956 Reduced 7.01%
12,686 $356 Million
Q4 2020

Jun 22, 2023
SELL
$24.2 - $35.76 $23,135 - $34,186
-956 Reduced 7.01%
12,686 $329,000
Q3 2020

Jun 26, 2023
SELL
$31.18 - $52.71 $29,808 - $50,390
-956 Reduced 7.01%
12,686 $471,000
Q2 2020

May 24, 2024
BUY
$30.04 - $51.31 $381,087 - $650,918
12,686 New
12,686 $651 Million
Q2 2020

Jun 26, 2023
SELL
$30.04 - $51.31 $28,718 - $49,052
-956 Reduced 7.01%
12,686 $650,000
Q2 2020

Mar 22, 2023
BUY
$30.04 - $51.31 $53,621 - $91,588
1,785 Added 16.37%
12,686 $650,000
Q2 2020

Aug 14, 2020
BUY
$30.04 - $51.31 $53,621 - $91,588
1,785 Added 16.37%
12,686 $651,000
Q1 2020

Jul 12, 2023
SELL
$27.44 - $73.84 $75,213 - $202,395
-2,741 Reduced 20.09%
10,901 $343,000
Q4 2019

Jul 12, 2023
SELL
$35.4 - $59.82 $97,031 - $163,966
-2,741 Reduced 20.09%
10,901 $650,000
Q3 2019

Jul 12, 2023
SELL
$34.47 - $47.53 $94,482 - $130,279
-2,741 Reduced 20.09%
10,901 $399,000
Q2 2019

Jul 12, 2023
SELL
$40.1 - $52.33 $109,914 - $143,436
-2,741 Reduced 20.09%
10,901 $507,000
Q1 2019

Jul 13, 2023
SELL
$40.11 - $53.57 $109,941 - $146,835
-2,741 Reduced 20.09%
10,901 $437,000
Q4 2018

Jul 13, 2023
SELL
$36.99 - $59.11 $101,389 - $162,020
-2,741 Reduced 20.09%
10,901 $501,000
Q4 2018

Mar 22, 2023
SELL
$36.99 - $59.11 $222,383 - $355,369
-6,012 Reduced 35.55%
10,901 $501,000
Q4 2018

Feb 14, 2019
SELL
$36.99 - $59.11 $222,383 - $355,369
-6,012 Reduced 35.55%
10,901 $501,000
Q3 2018

Jul 13, 2023
SELL
$40.74 - $51.41 $111,668 - $140,914
-2,741 Reduced 20.09%
10,901 $483,000
Q3 2018

Mar 22, 2023
SELL
$40.74 - $51.41 $724,072 - $913,709
-17,773 Reduced 51.24%
16,913 $750,000
Q3 2018

Nov 14, 2018
BUY
$40.74 - $51.41 $244,928 - $309,076
6,012 Added 55.15%
16,913 $750,000
Q2 2018

Aug 15, 2018
BUY
$36.2 - $76.4 $121,740 - $256,933
3,363 Added 44.61%
10,901 $427,000
Q4 2017

Feb 15, 2018
BUY
$43.47 - $67.43 $327,676 - $508,287
7,538
7,538 $496,000

Others Institutions Holding ESPR

# of Institutions
206
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $146M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email